Gov. Gianforte attends the first state-sponsored mAb clinic in late October at St. James in Butte. (Provided by the Governor’s Office.)
Gov. Greg Gianforte announced Monday the state is expanding access to life-saving monoclonal antibody (mAb) treatments with the opening of a new state-sponsored clinic in Missoula, according to a news release from his office. The Governor’s Office noted this is the second state-sponsored mAb clinic in Montana.
“A life-saving tool for Montanans who contract COVID-19, monoclonal antibody treatments help reduce the strain on our hospital systems and open up ICU beds for the most critical patients,” Gianforte said in a statement. “We are excited to provide Montanans expanded access to early treatment through the opening of this new, state-sponsored clinic in Missoula.”
The new clinic at Providence St. Patrick Hospital in Missoula will use staff and resources through Jogan Health Solutions, a third party with which the state contracted to alleviate the strain on hospital resources, the news release said. The monoclonal antibody treatment center is open to eligible, at-risk Montanans with a referral from their medical provider.
“While monoclonal antibodies are an important piece of the COVID-19 toolkit, they are only given with physician prescription once a person has contracted the virus. COVID vaccination remains the key measure in preventing a patient’s possible hospitalization and death,” said Joyce Dombrouski, chief executive of Providence Montana, in a statement provided by the Governor’s Office. “Partnering with the State of Montana for staffing was integral in our ability to offer this treatment locally.”
The locations of state-sponsored mAb clinics are as follows, the news release said:
Providence Surgery Center
902 North Orange
Missoula, Montana 59802
St. James Healthcare
400 S Clark Street
Butte, Montana 59701
While promoting the use of mAb to treat COVID-19, the governor stressed in the news release that the most effective protection against the virus remains safe, effective, and free COVID-19 vaccines.
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.